Close

Ratings by BofA Securities (Alec Stranahan)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/28/2024 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
1/5/2024 Erasca Inc ERAS Downgrade Neutral
(Buy)
2.16
(2.06)
-4.63% Details
1/5/2024 Revolution RVMD Upgrade Buy
(Neutral)
28.03
(32.23)
14.98% Details
11/15/2023 Y-mAbs Therapeutics YMAB Maintain Neutral
(N/A)
 
 
  Details
11/15/2023 MeiraGTx Holdings plc MGTX Maintain Buy
(N/A)
 
 
  Details
5/25/2023 Krystal Biotech KRYS Maintain Buy
(N/A)
 
 
  Details
5/19/2023 Xencor, Inc. XNCR New Coverage Buy
(N/A)
26.05
(22.13)
-15.05% Details
5/15/2023 Y-mAbs Therapeutics YMAB Maintain Neutral
(N/A)
 
 
  Details
4/19/2023 Erasca Inc ERAS Maintain Buy
(N/A)
 
 
  Details
12/29/2022 TG Therapeutics TGTX Maintain Underperform
(N/A)
 
 
  Details
12/15/2022 Erasca Inc ERAS Maintain Buy
(N/A)
 
 
  Details
12/15/2022 Y-mAbs Therapeutics YMAB Maintain Neutral
(N/A)
 
 
  Details
12/15/2022 Galecto GLTO Maintain Buy
(N/A)
 
 
  Details
12/15/2022 MeiraGTx Holdings plc MGTX Maintain Buy
(N/A)
 
 
  Details
12/15/2022 Regenxbio Inc. RGNX Maintain Buy
(N/A)
 
 
  Details
12/15/2022 Novavax NVAX Maintain Underperform
(N/A)
 
 
  Details
12/2/2022 Y-mAbs Therapeutics YMAB Downgrade Neutral
(Buy)
4.50
(16.26)
261.33% Details
12/1/2022 Spring Works Therapeutics SWTX New Coverage Buy
(N/A)
24.18
(49.22)
103.56% Details
10/10/2022 Novavax NVAX Maintain Underperform
(N/A)
 
 
  Details
5/20/2022 TG Therapeutics TGTX New Coverage Underperform
(N/A)
6.04
(15.21)
151.82% Details
5/20/2022 Revolution RVMD New Coverage Neutral
(N/A)
15.16
(32.23)
112.6% Details
5/20/2022 Turning Point Therapeutics Inc. TPTX New Coverage Buy
(N/A)
35.36
(76.01)
114.96% Details
5/3/2022 Hutchison China MediTech Ltd. HCM Maintain Buy
(N/A)
 
 
  Details
1/18/2022 Krystal Biotech KRYS New Coverage Buy
(N/A)
62.28
(177.93)
185.69% Details
11/17/2021 NextCure Inc. NXTC Maintain Underperform
(N/A)
 
 
  Details
5/7/2021 Y-mAbs Therapeutics YMAB Upgrade Buy
(Neutral)
28.65
(16.26)
-43.25% Details
1/15/2021 Esperion Therapeutics ESPR Downgrade Neutral
(Buy)
26.75
(2.68)
-89.98% Details
1/15/2021 NextCure Inc. NXTC Downgrade Underperform
(Neutral)
13.07
(2.23)
-82.94% Details
1/15/2021 Y-mAbs Therapeutics YMAB Downgrade Neutral
(Buy)
49.98
(28.65)
-42.68% Details
10/7/2020 Y-mAbs Therapeutics YMAB Maintain Buy
(N/A)
 
 
  Details
9/15/2020 MeiraGTx Holdings plc MGTX New Coverage Buy
(N/A)
13.33
(6.07)
-54.46% Details
1/14/2020 NextCure Inc. NXTC Maintain Buy
(N/A)
 
 
  Details
11/13/2019 Neon Therapeutics NTGN Downgrade Neutral
(Buy)
1.88
(3.07)
63.3% Details